Dr. Amanda Rae O'Donnell, DO

Dr. O'Donnell practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Dr. O'Donnell's NPI, 1356839328, was assigned on April 25, 2018. Dr. O'Donnell graduated from University of New England, College of Osteo Medicine in 2018. Dr. O'Donnell holds Massachusetts license 1016191.

Dr. O'Donnell's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Dr. O'Donnell's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. Dr. O'Donnell is also affiliated with Mount Auburn Hospital. The medical group on file is Cambridge Health Alliance. Dmand AI also links Dr. O'Donnell to 1 more hospital and 1 medical group, each named with a free account. Dr. O'Donnell's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Donnell practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. O'Donnell's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. O'Donnell is licensed in Massachusetts.

CMS data shows 247 Medicare services from Dr. O'Donnell across 5 procedure codes in 2024, for 89 Medicare patients. Medicare paid $15,716 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. O'Donnell in 2024. The largest group is 75 to 84, with 32 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 57% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. O'Donnell's median patient age at 66, with 50% women.

In 2024, Dr. O'Donnell wrote 200 Medicare Part D claims for 58 patients. 80% of them were for generic drugs. CMS names the drug for 126 of them, across 7 drugs with 11 or more claims each, at $17,729 in total drug cost. In 2023, CMS named 77 claims across 5 drugs.

Dr. O'Donnell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. O'Donnell as offering telehealth.

CMS Open Payments shows 4 general payments to Dr. O'Donnell from 1 drug or device company in 2025. Education make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $15.

Dr. O'Donnell graduated from University of New England, College of Osteo Medicine in 2018.